The Swiss Medical Weekly accepts for consideration original and review articles from all fields of medicine. The quality of SMW publications is guaranteed by a consistent policy of rigorous single-blind peer review. All editorial decisions are made by research-active academics. The quality of the editorial work and publishing ethics are maintained without compromise by the editorial board. SMW adheres to the “Principles of Transparency and Best Practice in Scholarly Publishing”. The funding association responsible for the journal, the "Trägerverein Swiss Medical Weekly", guarantees the editorial independence of the journal. The editors have total responsibility, authority, and accountability for the scientific content of the Swiss Medical Weekly. In order to maintain editorial independence, the principles formulated by the World Association of Medical Editors ("The Relationship Between Journal Editors-in-Chief and Owners") are observed.

Articles are published continuously online and included in PubMed and Web of Science. Information on newly published articles also appears in the print journal Swiss Medical Forum, which is sent to all members of the Swiss Medical Association FMH.

The Swiss Medical Weekly has played a decisive role in Swiss clinical research. As a scientific platform, the journal has been contributing for 150 years to the promotion of young academics.

Previous titles: Correspondenz-Blatt für Schweizer Aerzte (1871-1919) and Schweizerische Medizinische Wochenschrift / Journal Suisse de Médecine (Schweiz Med Wochenschr) (1920-2000)

The Swiss Medical Weekly is the official scientific publication of the Swiss Society of General Internal Medicine, the Swiss Society of Infectiology, the Swiss Society of Rheumatology and the Swiss Society of Pulmonary Hypertension.

Abstracted/indexed in Index Medicus / MEDLINE; Directory of Open Access Journals (DOAJ); Current Contents / Science Citation Index; EMBASE; SCOPUS; ROAD; Crossref; Dimensions; Altmetric

Articles published in the Swiss Medical Weekly are preserved in CLOCKSS, a secure dark archive.

Prof. Dr. med. Dr. phil. Nikola Biller-Andorno

Director, Institute of Biomedical Ethics and History of Medicine, Center for Medical Humanities, University of Zurich, Switzerland

Prof. Dr. med. Stefan Borgwardt, PhD

Head of the Neuropsychiatry and Brain Imaging research group, Department of Psychiatry (UPK), University of Basel, Switzerland

Prof. Dr. med. Jean-Michel Dayer

Emeritus Professor of Medicine of the University of Geneva, Switzerland

Daniele De Luca, MD, PhD

Chief, Division of Pediatrics and Neonatal Critical Care, APHP, GHU Paris Saclay, “A.Beclere” Medical Center / Associate Professor of Neonatology, Paris Saclay University

Amit Dutt, PhD

Integrated Cancer Genomics Laboratory, Tata Memorial Centre, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Kharghar, Navi Mumbai, India

Prof. Dr. med. Aristomenis Exadaktylos

Director Department of Emergency Medicine, University Hospital Bern (Inselspital), Bern, Switzerland

Prof. Dr. med. Miodrag Filipovic

Deputy Head of the Clinic for Anesthesiology & Intensive Care, Kantonsspital St. Gallen, St. Gallen, Switzerland

Prof. Dr. med. Franco Folli

Professore Ordinario di Endocrinologia, Dipartimento di Scienze della Salute, Universita' degli Studi di Milano, Milano, Italy

Alexander Huber, PhD

Global CMC Head, Cell & Gene Therapy Unit, Novartis Pharma AG, Basel, Switzerland

"Public Service Open Access" means the publication of scientific content without costs for the authors and without costs for the readers. The editorial and publishing costs are borne by sponsors.

In the author-pays model, the costs are merely shifted from the readers to the authors. For Open Access journals, APCs (Article Processing Charges) can become an attractive business model that poses a major threat to the independence of editorial decisions: the more articles accepted, the higher the income for the journal. The exponential increase in the number of so-called "predatory publishers" in recent years clearly shows the dangers of this new business model.